WSJ : Analog Devices to Acquire Alif Semiconductor for $1.35 Billion Deal will e

Analog Devices to Acquire Alif Semiconductor for $1.35 Billion
Deal will expand segments such as data-center infrastructure and defense

  • Analog Devices agreed to acquire Alif Semiconductor for $1.35 billion in cash.
  • The deal is intended to expand Analog Devices’ total addressable market across segments such as data-center infrastructure and defense.
  • The transaction has been approved by both companies’ boards and is expected to close before the end of the year.

Analog Devices ADI 0.26%increase; up pointing triangle struck a deal to acquire Alif Semiconductor for $1.35 billion in cash, expanding its total addressable market across quickly growing segments such as data-center infrastructure and defense.

The companies said Wednesday that artificial intelligence is entering a new phase, as models move beyond interpreting words and images and instead begin to understand context and interact with the physical world.

That transformation requires advanced systems that are able to reason from signals such as motion, sound, vibration, radio waves and thermodynamics, while also operating locally within demanding power, latency, security and reliability constraints, the companies added.

Alif’s microcontrollers and fusion processors enable real-time sensor fusion, low-latency inference and on-device AI, bringing advanced intelligence to demanding physical systems, Analog Devices said.

“By combining Alif’s digital processing capabilities with our leadership in multi-modal sensing, signal processing, power, connectivity, and software, we can empower customers to create entirely new classes of secure, intelligent systems that sense, reason, and act locally in real time,” Analog Devices Chief Executive Vincent Roche said.

Under the terms of the agreement, Analog Devices will pay Alif’s stockholders $1.35 billion of upfront consideration in cash. The company may pay an incremental contingent consideration of up to $200 million, it added.

The transaction, which has already been approved by both companies’ boards of directors, is expected to close before the end of the year.

WSJ : Anthropic Researcher Quits Over ‘Out-of-Control’ AI Fears Concerns are ris



From: Laurent Chekroun (MAKOR CAPITAL MARKET) At: 09/09/26 06:44:24 UTC+2:00
Subject: WSJ : Anthropic Researcher Quits Over ‘Out-of-Control’ AI Fears Concerns are ris
Anthropic Researcher Quits Over ‘Out-of-Control’ AI Fears
Concerns are rising inside AI labs that competition is pushing tech companies to race toward self-improving models that risk spiraling out of human control

  • Anthropic researcher Jacob Coxon is quitting the AI industry over fears that companies are racing to build uncontrollable, self-improving systems.
  • Coxon believes no company can responsibly develop artificial general intelligence without government intervention or a coordinated industry slowdown.
  • The departure comes as Anthropic prepares for an initial public offering, seeking a $2 trillion valuation.

An Anthropic researcher is quitting the artificial-intelligence industry over fears that the lab and its competitors are racing to build systems they won’t be able to control, a sign of mounting safety concerns within top AI companies.

Jacob Coxon, a researcher who specializes in training new AI models by having them consume vast amounts of data, said Tuesday that he is leaving the company because he doesn’t want to participate in an industrywide rush to build AI systems that can improve themselves, worried such systems could spiral out of control and destroy humanity.

The 27-year old Brit, who previously studied mathematics, said many of his industry colleagues now use phrases like “crunchtime” and “endgame” to describe the trajectory toward self-improving models.

“We’re on track for a lot of the most aggressive of these scenarios where by the end of next year things could be out of control already,” Coxon said, adding that safety trade-offs are inevitable when companies are competing against one another and Chinese upstarts.

Anthropic didn’t immediately comment on the departure. Chief Executive Dario Amodei and other company leaders have repeatedly warned about the risks of rogue AI models, and urged the industry to slow development.

Coxon said he left OpenAI earlier this year to join Anthropic because it is known for its model-safety efforts. But even though he found Anthropic’s safety efforts to be earnest, he now believes no company can responsibly develop AI that can outperform humans in a range of tasks, sometimes called artificial general intelligence, absent government intervention or a coordinated industry slowdown.

Recent hacks by models from OpenAI and Anthropic, some operating in collaborative swarms of agents, have illustrated how AI systems can adopt nefarious goals and try to conceal them from humans. Once the systems begin to improve on their own, Coxon said, he fears they could advance enough to refuse commands.

Coxon’s departure is one of the first examples of an Anthropic employee leaving over AI safety fears. A researcher working on safety left the company earlier this year to study poetry, warning that “the world is in peril.”

Several researchers have left OpenAI and other companies recently and in past years citing similar worries. Anthropic has built one of the largest AI platforms in part by claiming it gives priority to responsible AI development and invests heavily in the space.

Industry leaders have been warning that recent cyberattacks are a harbinger. OpenAI told reporters last week that its latest model represented artificial general intelligence and a big step up in capabilities.

“I think some things are going to go very wrong with cybersecurity unless people act quite urgently,” OpenAI CEO Sam Altman told Group of 20 officials last week at a summit in North Carolina.

“This is a time that calls for extreme caution. I am concerned no one is prepared for the consequences of a continued rapid rise in machine intelligence,” Jakub Pachocki, OpenAI’s chief scientist, wrote in a Sunday blog post advocating for a coordinated industry slowdown and government intervention.

Coxon, Pachocki and Amodei joined more than 1,000 AI researchers across the industry who recently signed a statement urging global government coordination on a system to slow AI development if a brake pedal is needed to control models capable of improving on their own. There are no federal AI regulations, and the Trump administration has given priority to a light-touch approach to maximize the economic benefits of AI, an environment critics say could lead to massive cyberattacks or other harms.

Sen. Bernie Sanders (I., Vt.) and Rep. Greg Casar (D., Texas), progressives who are two of the only lawmakers proposing AI guardrails, last week introduced legislation to permanently ban superintelligence and pause model development until an industry regulator established new rules.

Coxon’s departure comes with Anthropic gearing up for an initial public offering that is expected to be among the largest ever. The company is seeking a $2 trillion valuation and has emphasized responsible development of the technology when attracting investors. Amodei and company leaders have fought the Trump administration and other executives at times over practices they say don’t prioritize AI safety.

Anthropic uses an employee Slack channel to hold discussions about the powerful capabilities of their models, Coxon said, describing it as a reflection of how much influence AI companies have over the industry’s development.

“It’s kind of insane that it has to happen on the MacBooks of some engineers living in San Francisco instead of a bunker in the desert like where they were doing the Manhattan Project,” Coxon said.

FT : Saudi Arabia’s other war enters dangerous new chapter Iran-backed Houthis l

Saudi Arabia’s other war enters dangerous new chapter
Iran-backed Houthis launch biggest attack on the kingdom in years this week, taking their conflict to a new level

By launching the biggest attack on Saudi Arabia in years, firing dozens of missiles and drones at energy facilities across the south, the Iran-backed Houthis have taken their conflict with the kingdom to a new level.

The Yemeni group’s assault this week targeted energy sites and a military base across four Saudi cities, raising the stakes in another of the Middle East’s long-running conflicts and dragging Riyadh back into a conflict it had in recent years sought to extract itself from.

The attacks, which analysts said came in waves beginning in the early hours of Tuesday, wounded more than 70 people and temporarily halted some energy operations as emergency workers sought to contain fires, helping push oil prices towards $100 a barrel.

While Saudi Arabia avoided the worst of Iran’s attacks on the Gulf during the height of the US-Israeli war with Iran, this week’s assault highlighted the dangers posed by a battle-hardened enemy dug deep in rugged mountains across its southern border.

“The fact [the Houthis] are now hitting these cities really highlights Saudi Arabia’s vulnerability and its danger of being pulled into this conflict far further than it would have wanted,” said Neil Quilliam, an associate fellow at Chatham House. “Simultaneous attacks on several cities tell you something about the Houthis’ improved capabilities.”

This week’s assault came after the Houthis had, in recent weeks, attacked tankers in the Red Sea and launched fresh offensives against Saudi-backed Yemeni forces, reigniting the conflict and shattering a 2022 ceasefire.

The campaign is already affecting the kingdom’s ability to ship oil. Alongside attacking tankers, the rebels have threatened to close the Bab al-Mandeb Strait, which has become a vital crude export route on Saudi Arabia’s west coast. Riyadh had been able to move exports to the Red Sea via a pipeline after Iran throttled shipping through the Strait of Hormuz.

Last month, the kingdom’s tracked crude exports fell to about 3mn barrels a day, the lowest level in at least 13 years, due to threats in both waterways, according to data from Kpler.

The Saudi energy ministry did not say which facilities were hit in Tuesday’s attack or provide details of the damage.

Saudi Arabia has drawn less Iranian fire than many neighbours partly because areas of the vast nation were too far for Iran’s short-range missiles, while Riyadh also maintained diplomatic channels with Tehran and sought to de-escalate, analysts say.


While oil output dropped and the Saudi economy suffered the steepest quarterly decline since the Covid-19 pandemic, higher crude prices meant its oil revenue actually increased.

But in the background, the Houthi threat has simmered on its doorstep. The Houthis largely stayed out of the Iran war beyond firing several salvos of missiles and drones at Israel, and the four-year truce with Saudi Arabia held.

But in July, hostilities began to flare up, with the Houthis declaring a blockade on Saudi ports, attacking the kingdom’s tankers in the Red Sea and targeting its energy facilities.

The Houthis’ belligerence serves Iran’s interests by increasing pressure on energy prices, analysts say, but the rebels, feeling emboldened, are also seeking to pressure Saudi Arabia to make financial concessions to them. This includes paying salaries in areas under Houthi control, giving them access to oil revenues from Yemeni government-controlled areas and paying compensation for war losses.

Saudi Arabia, however, viewed the Houthis’ demands as tantamount to extortion, and analysts say it spent months arming and training forces aligned to the Yemeni government to prepare for any escalation.

The build-up of anti-Houthi forces caused the rebels to launch what was widely viewed as a pre-emptive offensive along the Red Sea coast over the weekend, in a bid to advance south towards the Bab al-Mandeb Strait.

The Saudi-backed Yemeni forces, armed with new types of drones, have since mounted their own counteroffensive on multiple fronts.

Mohammed Albasha, founder of the US-based risk advisory firm Basha Report, said the counteroffensive has put the Houthis under the most significant pressure since 2022. But, he added, the rebels would “fight tooth and nail rather than simply fold”.

“This is the beginning of the full-scale war and it’s going to be a protracted conflict, there’s not going to be a quick win,” Albasha said. “All sides have been preparing for years.”

The Houthis on Tuesday accused Saudi Arabia of launching more than 120 air strikes across Yemen since the weekend, alleging that one strike hit a prison, killing inmates. Houthi-controlled media then said the kingdom carried out more strikes on Wednesday.

The militant group said it carried out Tuesday’s “large-scale military operation” in retaliation. Riyadh said the Houthis targeted the cities of Abha, Khamis Mushait, Jizan and Najran.

A Saudi military spokesperson said the Saudi-led coalition fighting in Yemen would take “all necessary operational measures to deter this terrorist militia” and “neutralise its danger”.

Ali Shihabi, a Saudi commentator familiar with Riyadh’s thinking, said the kingdom anticipated an escalation was coming and had been building up the Yemeni government-aligned forces for months.

“The Houthis are getting hit badly on the battlefield,” he said. “They are suffering and lashing out, so this was expected.”

Stockpiles of missile interceptors that are vital to air-defence systems have come under strain across the region in the wake of Iran’s retaliatory attacks on the US’s Arab allies.

Shihabi said the Saudis had been replenishing their stocks. “Riyadh knew this was coming,” he said.

But the escalation brings high risks for the kingdom as Saudi Crown Prince Mohammed bin Salman seeks to push ahead with his ambitious plans to develop his nation.

Prince Mohammed spearheaded the intervention by an Arab coalition in Yemen’s civil war after the Houthis ousted the Yemeni government in 2015. But Riyadh got bogged down in a conflict that cost billions of dollars and drew widespread condemnation for coalition air strikes that killed thousands of civilians.

He then sought to withdraw from the conflict as almost daily Houthi missile and drone strikes undermined his modernisation plans.

Most Houthi fire was intercepted, but missiles that got through air defences hit energy infrastructure, airports and other key sites, tarnishing his efforts to project the kingdom as a regional hub.

The disparate anti-Houthi forces, meanwhile, are made up of myriad factions that often have competing interests and have previously failed to weaken the rebels’ hold over Yemeni capital Sana’a.

If the kingdom becomes embroiled in a renewed, protracted conflict, it would further dent its ability to attract badly needed foreign investment to back its plans, analysts say.

The Houthis previously disrupted shipping through the Red Sea for nearly two years after Hamas’s October 7 2023 attack on Israel, despite US bombing campaigns against the rebels.

“If Bab al-Mandeb does come under threat and it becomes a real blockade, Saudi Arabia is squeezed on both sides and has very few options,” said Quilliam. “The fact that they had been able to switch [oil exports] from the east to the west coast gave them that safety valve and that’s under threat.”

He added: “The focus for the kingdom is going to be security right now.”

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • TTAN -17.8% (also CRO to step down), CASY -11%, BRZE -10.6%, SAIL -4.4%, SFD -3.5% (guidance)
Other news:
  • TYRA -22.5% (posts initial Phase 2 SURF302 data for dabogratinib in LG IR NMIBC)
  • PYXS -20.7% (posts updated Phase 1 MICVO data in recurrent/metastatic head and neck cancer)
  • EVMN -8.4% (EVO756 misses Phase 2b primary endpoint in atopic dermatitis; will not advance program in AD)
  • BKV -6.8% (launches $400 mln convertible senior notes offering due 2031)
  • TH -5.7% (prices 14M-share secondary at $18.50; to repurchase about $30 mln of stock)
  • IRT -5.7% (Independence Realty Trust and Centerspace (CSR) to merge in $8.1 billion combination)
  • INGM -5.6% (prices 13.125M-share secondary at $27.25; authorizes concurrent stock repurchase)
  • RZLT -4.1% (FDA still reviewing Phase 3 sunRIZE data for ersodetug in congenital HI)
  • LFST -3.9% (launches 22.25 mln-share secondary offering; authorizes concurrent 2.0 mln-share buyback)
  • SB -3.8% (contemplating a private placement of approximately 12,000,000 new shares of common stock)
  • SNAP -1.6% (names new Chief Commercial Officer)
  • BILI -1.5% (confirmed the completion of $500 mln 2031 convertible notes offering; Tencent-related $200 mln note subscription, share repurchase still pending)
  • TPG -1.3% (discloses departure of President)
  • AHCO -1.3% (names new CFO)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • ODD +26.4%, SIG +16.1%, JILL +14.4%, INNV +13.7%, AVO +5.7%, CAL +5%, CHWY +3.7%, SUNB +3.2%, FTK +3.1% (guidance), KFY +1.7%, ASX +1.2% (Aug revs), JMKE +0.5%
Other news:
  • CHYM +9.6% (to acquire Stride Bank for $590 mln in cash; also offers guidance)
  • CMTG +8.4% (CEO/Chairman discloses insider purchase)
  • CSR +7.5% (Independence Realty Trust and Centerspace (CSR) to merge in $8.1 billion combination)
  • IRD +5.3% (reports positive Phase 1/2 OPGx-BEST1 cohort data; FDA aligns on potential pivotal endpoint)
  • ASR +4.9% (reports August passenger traffic)
  • INBX +4.9% (discloses insider purchases)
  • ASMB +4.7% (exercises U.S. profit-share option with GILD for HSV program)
  • EIKN +4.1% (10% Owner discloses insider purchase)
  • SPTX +3.9% (Phase 1 driving trial met endpoints for GlyphAllo)
  • WS +3.8% (signs profit transfer agreement with Kloeckner after takeover)
  • AUTL +3.8% (FDA grants RMAT designation to obe-cel in lupus indications)
  • CMPS +3.1% (posts 52-week Phase 3 COMP005 data for COMP360 in TRD)
  • JKS +3% (proposes name change to Jinko Holdings, outlines strategic investment focus)
  • CSAN +3% (confirmed last trading day of the ADSs on the NYSE will be September 18)
  • RKLB +2.9% (launches germanium-free IMM Apex solar cell for space applications)
  • BETR +2.3% (COO to depart)
  • GENI +2.3% (launches new athlete-led sports media venture)
  • MNKD +2.3% (enters Rose Pharma licensing deal for inhaled GLP-1 weight-management program)
  • AVEX +2.2% (wins $20.5 mln in new one-way attack system awards)
  • XNDU +2.2% (partners with ASML on lithography for photonic quantum chips)
  • KROS +2.1% (authorizes new $5 mln share repurchase program)
  • CAMP +1.8% (to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder)

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • INNV +16.6%, CHYM +9.9%, AVO +7.2%, CMTG +5.2%, PYXS +4.9%, ASR +4.9%, ASMB +4.7%, CSR +4.3%, EIKN +4.1%, FTK +3.5%, INBX +3.2%, RKLB +3%, CSAN +3%, JKS +2.8%, GENI +2.3%, KROS +2.1%, CNXC +2%, IDYA +1.9%, BETR +1.5%, SYY +1.4%, XPOF +1.3%, LYFT +1%, ASX +1%, OCGN +0.8%, NNI +0.7%, PTGX +0.7%, LTM +0.7%, CMPS +0.7%, MNKD +0.7%
  • Gapping down:
    • TTAN -17.2%, EVMN -13.8%, BRZE -10.8%, CASY -9.6%, TH -6.1%, SB -4.8%, INGM -3.1%, AHCO -3.1%, CWEN -3.1%, SFD -2.8%, SNAP -2.2%, CNL -1.9%, T -1.2%, IRT -1.1%, TPG -1%, AMKR -0.9%

>>> US Research Calls

Research Calls I
  • Upgrades:
    • Figure Technology (FIGR) upgraded to Neutral from Underperform at BofA, tgt $49
    • Lineage (LINE) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $47
    • Martin Marietta (MLM) upgraded to Overweight from Equal Weight at Wells Fargo, tgt $609
    • Sagimet Biosciences (SGMT) upgraded to Overweight from Equal Weight at Barclays, tgt $18
    • Sasol (SSL) upgraded to Buy from Neutral at BofA
    • Summit Therapeutics (SMMT) upgraded to Buy from Hold at Jefferies, tgt $25
    • Thermo Fisher (TMO) upgraded to Buy from Neutral at UBS, tgt $730
    • UGI Corporation (UGI) upgraded to Buy from Hold at Jefferies, tgt $43
  • Downgrades:
    • Amrize (AMRZ) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $44
    • Dyne Therapeutics (DYN) downgraded to Underweight from Neutral at JPMorgan, tgt $10
    • Eagle Materials (EXP) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $196
    • LVMH (LVMUY) downgraded to Hold from Buy at HSBC
    • Novartis (NVS) downgraded to Hold from Buy at Deutsche Bank
    • Patria Investments (PAX) downgraded to Underperform from Neutral at BofA, tgt $10
    • Vulcan Materials (VMC) downgraded to Underweight from Equal Weight at Wells Fargo, tgt $254
    • Westlake (WLK) downgraded to Market Perform from Outperform at BMO Capital, tgt $82
  • Others:
    • Abercrombie & Fitch (ANF) initiated with an Outperform at BMO Capital
    • Academy Sports (ASO) initiated with a Market Perform at BMO Capital
    • AEON Biopharma (AEON) initiated with a Buy at Laidlaw
    • Affirm (AFRM) initiated with a Buy at Loop Capital
    • Aktis Oncology (AKTS) initiated with an Outperform at Oppenheimer
    • Amneal Pharmaceuticals (AMRX) initiated with an Outperform at Leerink
    • American Eagle (AEO) initiated with a Market Perform at BMO Capital
    • Amer Sports (AS) initiated with an Outperform at BMO Capital
    • Aptiv (APTV) initiated with a Buy at StoneX
    • Argan (AGX) initiated with an Underweight at Piper Sandler
    • Array Technologies (ARRY) initiated with a Neutral at Piper Sandler
    • AstraZeneca (AZN) initiated with an Outperform at RBC Capital
    • Bath & Body Works (BBWI) initiated with a Market Perform at BMO Capital
    • Bausch + Lomb (BLCO) initiated with an Outperform at Leerink
    • Birkenstock (BIRK) initiated with a Market Perform at BMO Capital
    • Caris Life Sciences (CAI) initiated with a Neutral at UBS
    • Carter's (CRI) initiated with an Outperform at BMO Capital
    • Chime (CHYM) initiated with a Buy at Loop Capital
    • Cigna (CI) initiated with an In Line at Evercore ISI
    • Collegium Pharmaceutical (COLL) assumed with a Buy at Truist
    • Danaher (DHR) assumed with a Buy at UBS
    • Dave (DAVE) initiated with a Buy at Loop Capital
    • Deckers Outdoor (DECK) initiated with an Underperform at BMO Capital
    • Dick's Sporting Goods (DKS) initiated with an Underperform at BMO Capital
    • DoorDash (DASH) initiated with an Outperform at Scotiabank
    • Faeth Therapeutics (FTH) initiated with a Buy at TD Cowen
    • First Solar (FSLR) initiated with an Overweight at Piper Sandler
    • Fluence Energy (FLNC) initiated with an Underweight at Piper Sandler
    • Gap (GAP) initiated with a Market Perform at BMO Capital
    • GRAIL (GRAL) assumed with a Buy at UBS
    • GSK (GSK) initiated with a Sector Perform at RBC Capital
    • Harrow (HROW) initiated with an Outperform at Leerink
    • Heartflow (HTFL) assumed with a Neutral at UBS
    • Illumina (ILMN) resumed with a Buy at UBS
    • Klarna (KLAR) initiated with a Hold at Loop Capital
    • Kodiak AI (KDK) initiated with a Buy at Needham
    • Liberty Formula One (FWONK) initiated with a Buy at Jefferies
    • Lindblad Expeditions (LIND) initiated with a Hold at Jefferies
    • Lithium Americas (LAC) assumed with an Overweight from Neutral at JPMorgan
    • Lululemon (LULU) initiated with an Underperform at BMO Capital
    • Lyft (LYFT) initiated with a Sector Perform at Scotiabank
    • Magna (MGA) initiated with a Buy at StoneX
    • MasTec (MTZ) initiated with an Overweight at Piper Sandler
    • Mobility Global (MBGL) initiated with an In Line at Evercore ISI
    • Monarch Casino (MCRI) initiated with a Buy at Texas Capital
    • Nautilus Biotechnology (NAUT) initiated with an Outperform at Leerink
    • Nextpower (NXT) initiated with an Overweight at Piper Sandler
    • Nike (NKE) initiated with an Underperform at BMO Capital
    • Novartis (NVS) initiated with a Sector Perform at RBC Capital
    • Obsidian Therapeutics (OBX) initiated with an Outperform at William Blair
    • Oklo (OKLO) initiated with an Overweight at Piper Sandler
    • On Holding (ONON) initiated with a Market Perform at BMO Capital
    • Pacira Pharmaceuticals (PCRX) initiated with a Market Perform at Leerink
    • Pasqal (PSQL) initiated with a Buy at Roth Capital
    • Phathom Pharmaceuticals (PHAT) initiated with a Market Perform at Leerink
    • Primoris (PRIM) initiated with a Neutral at Piper Sandler
    • Pulse Biosciences (PLSE) initiated with a Buy at Freedom Capital
    • Pursuit Attractions (PRSU) initiated with a Buy at Jefferies
    • Quanta Services (PWR) initiated with an Overweight at Piper Sandler
    • Red Rock Resorts (RRR) initiated with a Buy at Texas Capital
    • Robinhood (HOOD) initiated with a Buy at StoneX
    • Roche (RHHBY) initiated with an Outperform at RBC Capital
    • Sagimet Biosciences (SGMT) initiated with an Overweight at Cantor Fitzgerald
    • Sanofi (SNY) initiated with a Sector Perform at RBC Capital
    • SoFi Technologies (SOFI) initiated with a Hold at Loop Capital
    • Steven Madden (SHOO) initiated with an Outperform at BMO Capital
    • Teva (TEVA) initiated with an Outperform at Leerink
    • TriSalus Life Sciences (TLSI) initiated with a Buy at H.C. Wainwright
    • Uber (UBER) initiated with an Outperform at Scotiabank
    • Ulta Beauty (ULTA) initiated with a Market Perform at BMO Capital
    • Upstart (UPST) initiated with a Hold at Loop Capital
    • Urban Outfitters (URBN) initiated with a Market Perform at BMO Capital
    • Viatris (VTRS) initiated with an Outperform at Leerink
    • Victoria's Secret (VSXY) initiated with a Market Perform at BMO Capital
    • X-energy (XE) initiated with an Underweight at Piper Sandler
    • XPeng (XPEV) initiated with a Neutral at UBS

>>> Europe : Brokers Upgrades & Downgrades - 9th of Sept 2026 V2(+)

>>> Up
* Adecco price target raised to CHF 18.50 from CHF 16 at Morgan Stanley
* Hannover Re Raised to Buy at Intesa Sanpaolo; PT 307 euros (+)
* Kingspan Raised at JPMorgan, Selective in Building Materials
* Kinnevik Raised to Buy at SEB Equities; PT 74 kronor
* LVMH Raised to Outperform at Grupo Santander; PT 500 euros
* Robert Walters Raised to Buy at Deutsche Bank; PT 160 pence (+)
* Thermo Fisher Raised to Buy at UBS

>>> Down
* Allianz Cut to Underperform at Intesa Sanpaolo; PT 403 euros (+)
* Autoliv Cut to Hold, Dauch Boosted to Buy at TD Cowen
* Beiersdorf Cut to Sell at Deutsche Bank (+)
* Burberry Cut to Hold at HSBC; PT 1,200 pence
* Coloplast Cut to Underweight at JPMorgan
* Forterra plc price target lowered to 150 GBp from 170 GBp at Berenberg
* IQE price target lowered to 65 GBp from 70 GBp at Deutsche Bank
* LVMH Cut to Hold at HSBC; PT 490 euros
* NN Group Cut to Hold at ING; PT 74 euros
* Novartis Cut to Hold at Deutsche Bank; PT 120 Swiss francs
* Novartis ADRs Cut to Hold at Deutsche Bank
* Scor Cut to Neutral at Intesa Sanpaolo; PT 37 euros (+)
* SSH Communications Security Cut to Sell at Inderes; PT 2 euros
* Swiss Re Cut to Underperform at Intesa Sanpaolo (+)
* Vend Marketplaces Cut to Equal-Weight at Morgan Stanley

>>> Initiation
* AstraZeneca Rated New Outperform at RBC; PT 14,500 pence
* Autotrader Group PLC Reinstated Sell at Stifel; PT 431 pence
* Birkenstock Rated New Market Perform at BMO; PT $35
* Deckers Outdoor Rated New Underperform at BMO
* Dick's Sporting Rated New Underperform at BMO
* Gens Aurea Rated New Neutral at BNP Paribas; PT 14 euros
* GSK Rated New Sector Perform at RBC; PT 1,975 pence
* Liberty Formula One Rated New Buy at Jefferies; PT $115
* Lululemon Rated New Underperform at BMO
* Nokian Panimo Rated New Reduce at Inderes; PT 2.40 euros
* Novartis Rated New Sector Perform at RBC; PT 120 Swiss francs
* Oklo Rated New Overweight at Piper Sandler on Growth Potential
* On Holding Rated New Market Perform at BMO
* Pasqal Holding Rated New Buy at Roth Capital Partners; PT $20
* Prosus Rated New Buy at Stifel; PT 50 euros
* Richter Rated New Neutral at Oddo BHF; PT 14,000 forint
* Rightmove Rated New Sell at Stifel; PT 356 pence
* Roche Rated New Outperform at RBC; PT 400 Swiss francs
* Sanofi Rated New Sector Perform at RBC; PT 80 euros
* Scout24 Rated New Buy at Stifel; PT 110 euros
* SMG Swiss Marketplace Group Rated New Buy at Stifel
* Steven Madden Rated New Outperform at BMO
* Urban Outfitters Rated New Market Perform at BMO
* Victoria's Secret Rated New Market Perform at BMO

>>> Call
* Astra, Roche Started at Outperform as RBC Initiates EU Pharma (+)
* Barclays Says Europe Rally Stalls on Energy, Rates and Politics (+)
* Givaudan Strikes ‘Constructive Tone’ at Barclays Conference
* JPMorgan Stays Cautious on MedTech, Coloplast Cut to Underweight
* Kinnevik Gets Upgraded at SEB as Analysts Say Tide Has Turned (+)
* Nike and Lululemon Both Rated New Underperforms at BMO
* Richter Undertaking Gradual Transformation, Oddo BHF is Neutral
* Scout24 Now a Top Pick at Morgan Stanley, Vend Marketplaces Cut

Reuters - OpenAI says working with Samsung on next-generation chips, deepening c

OpenAI says working with Samsung on next-generation chips, deepening cooperation

  • OpenAI says deepens Samsung ties through joint research on developing chips
  • ChatGPT maker sees continued growth in memory chip demand
  • OpenAI strengthens ties with South Korean chip supply chain

SEOUL, Sept 9 (Reuters) - OpenAI is deepening cooperation with Samsung Electronics (005930.KS), opens new tab as the ChatGPT maker develops ‌its own chips, expanding ties with the South Korean technology giant across semiconductors and enterprise AI services.

"One of the areas where we have made the most progress and gained the most recognition with Samsung Electronics is our joint production and ​research on the next-generation chips we are developing," Harrison Kim, General Manager of OpenAI Korea, said at ​a press conference in Seoul on Wednesday, without elaborating.

Kim also said Samsung Electronics was "one of the ⁠largest-scale deployments of ChatGPT globally," saying the company's employees in Korea and overseas use ChatGPT for work ​across research and development, marketing and sales.

Samsung Electronics said in a statement that it could not confirm information ​related to customers.

In June, OpenAI unveiled its first custom artificial intelligence chip designed with Broadcom (AVGO.O), opens new tab. OpenAI's engineers designed the chip, called Jalapeno, together with Broadcom for a task known as AI inference, the process of crunching data to answer queries in applications ​such as ChatGPT.

OpenAI at that time said that Taiwan's TSMC (2330.TW), opens new tab would manufacture the chips.

Last year, Samsung Electronics ​and SK Hynix (000660.KS), opens new tab signed letters of intent to supply memory chips for OpenAI's Stargate data centre project.

Kim said demand for ‌memory chips ⁠would continue to grow as more advanced chips were needed to enable faster and more complex computing, making cooperation with South Korean semiconductor suppliers a priority for OpenAI's local office.

The cooperation comes as Samsung broadens its use of generative AI. The company said in June that workers in its Device eXperience division, which ​oversees mobile phones, televisions and ​home appliances, would be allowed ⁠to use ChatGPT, Google's (GOOGL.O), opens new tab Gemini and Anthropic's Claude internally.

OpenAI said the number of ChatGPT Enterprise users at South Korean companies and institutions had surged about 28-fold as ​of the end of August from a year earlier, as businesses broadened their ​use of ⁠artificial intelligence from individual tasks to company-wide operations.

Companies were increasingly using AI across functions including legal, sales, finance, marketing and operations, OpenAI said. The company declined to provide absolute user numbers.

South Korea had the largest number of ⁠paying ChatGPT ​subscribers outside the United States as of late last year, according ​to OpenAI.

OpenAI expects adoption to accelerate following the September 4 launch of GPT-6 Astra, its latest model, which it said offered improved performance ​in computer use, professional work, science, coding and cybersecurity.